Harnessing FDA-approved dipyridamole to inhibit NLRP3 inflammasome and improve outcomes of acute lung injury in sepsis - Xiuhui Chen; Yutong Zheng; Xiaofeng Zhang; Anran Zheng; Junjun Huang; Guoliang Deng; Xuna Wu; Yuying Peng; Xiaoling Zhang; Renshan Chen; Qing Xiao; Weijun Ye (Toxicology and Applied Pharmacology, 2025)